Market Segmentation Tab
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Regional Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Product & Service Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Screening Type Outlook (USD Billion, 2018-2030)
Transplant Diagnostics Organ Type Outlook (USD Billion, 2018-2030)
Research Methodology on Transplant Diagnostics Market
Introduction
This research is based on “Transplant Diagnostics Market: Global Size, Trends, Competitive, Historical and Forecast Analysis, 2023-2030”. The report is an in-depth analysis of the Transplant Diagnostics Market and its opportunities. It provides detailed data and facts regarding the current and projected state of the market. The report also identifies the factors that are likely to propel or impede the growth of the market.
Research Methodology
The research methodology used in this report focuses on the application of quantitative and qualitative analysis techniques to forecast the state of the transplant diagnostics market. The primary research methodology is survey-based and involves interviews with key industry stakeholders, including leading vendors, industry experts, and opinion leaders. Secondary research is also conducted, including a comprehensive data search in a variety of databases, like PubMed and PubMed Central, for published material related to the industry. The secondary research involves further market exploration through magazine, journal and newspaper articles, as well as governmental and other reports.
Research Objectives
The primary objectives of this research are to:
Data collection and analysis
Data is collected via online surveys, focus groups and by conducting interviews with industry experts and stakeholders. The collected data is then analyzed to draw meaningful insights and to identify opportunities present in the global transplant diagnostics market. Quantitative analysis is done using the Delphi method, while qualitative analysis is done using a deductive approach through which logical conclusions are derived.
Data analyses
The collected data is then analyzed in the following stages:
Research Model
A research model is developed to understand and analyze the market factors that influence the growth of the transplant diagnostics market. This model is developed through market segmentation and then further validated through a combination of procedures.
Market Segmentation
The research is segmented into different sections to provide an accurate understanding of the market. The segments used are based on product type and end-users. The product segment is further subdivided into products such as test kits and reagents, instruments, specialized software and equipment. The end-user segmentation is subdivided into hospitals, clinics, research laboratories and clinical laboratories.
Data Validation
While the data is initially collected from various sources, validation is further conducted using various methodologies including primary and secondary validation techniques. Primary validation techniques include face-to-face interviews with stakeholders and experts. Secondary validation techniques include verifying the data obtained from various sources against industry reports and government publications.
Data Processing
Data processing is performed using various procedures such as data cleaning and data integration. Data cleaning is done using data scrubbing techniques to ensure that the quality of data was adequate for analysis. Data integration is done by combining different data sources to generate a set of connected facts.
Data interpretation
The interpreted data is analyzed to draw meaningful conclusions and to identify the most influential factors impacting the growth of the transplant diagnostics market. The analysis is done by analyzing the segmentation and the impact of that segment on the market. Further analysis is done by analyzing the relationships between the segment and other specific variables.
Conclusion
In conclusion, the research methodology used in this report combined survey-based research, and qualitative and quantitative analysis to forecast the state of the transplant diagnostics market. The primary research methodology is survey-based and includes interviews with key industry stakeholders, including leading vendors, industry experts, and opinion leaders. Secondary research is also conducted, including a comprehensive data search in a variety of databases, like PubMed and PubMed Central, for published material related to the industry. The research is also segmented into different sections to provide an accurate understanding of the market. The data is then validated, processed and interpreted to generate insights. The analysis is then used to identify the most influential factors impacting the growth of the transplant diagnostics market.
1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Scope of Study 25
3.2 Research Objective 25
3.3 List of Assumptions 25
3.4 Market Structure 26
4 Research Methodology
4.1 Primary Research Methodology 29
4.2 Data points received from the Specialist Doctors: 29
4.3 Data points received from the Manufacturer/ Pharmaceutical Companies: 30
4.4 Data points received from Hospitals, Diagnostic Centers: 31
4.5 Secondary Research Methodology 32
4.6 Market Share Analysis 33
4.7 Trade Analysis 34
4.8 Market Pricing Approach 34
4.9 Forecast Model 35
5 Market Dynamics
5.1 Introduction 37
5.2 Drivers 38
5.2.1 Growing number of stem cell, soft-tissue, and solid organ, transplantation procedures 38
5.2.2 Rising occurrence of chronic and infectious diseases 38
5.2.3 Increasing Awareness Related to Transplant Diagnostic Procedures 38
5.3 Restraints 39
5.3.1 Shortage of donor organ and limited medical reimbursement 39
5.3.2 High cost of NGS- and PCR-based devices 39
5.4 Opportunities 40
5.4.1 High demand for tissue engineering in cosmetic and reconstructive surgery 40
5.4.2 Growing geriatric population presents a significant growth opportunity 40
6 Market Factor Analysis
6.1 Porters Five Forces Analysis 42
6.1.1 Bargaining Power of Suppliers 42
6.1.2 Bargaining Power of Buyers 43
6.1.3 Threat of New Entrants 43
6.1.4 Threat of Substitutes 43
6.1.5 Intensity of Rivalry 43
6.2 Supply Chain Analysis 44
6.2.1 Primary activities 44
6.2.2 Secondary Activities 45
7 Immunosuppressant Drug Monitoring (ISD)
7.1 Overview 47
7.1 Diagnostic Tests for Transplantation 47
7.1.1 Therapeutic Drug Monitoring During Transplantation 47
7.2 Americas 48
7.2.1 North America 48
7.2.1.1 U.S. 50
7.2.1.2 Canada 51
7.2.2 South America 52
7.3 Europe 53
7.3.1 Germany 54
7.3.2 U.K 55
7.3.3 France 56
7.3.4 Spain 57
7.3.5 Italy 58
7.3.6 Rest of Europe 59
7.4 Asia Pacific 61
7.4.1 China 62
7.4.2 Japan 63
7.4.3 India 64
7.4.4 Australia 65
7.4.5 Rest of Asia Pacific 66
7.5 Middle East & Africa 68
7.5.1 Middle East 69
7.5.2 Africa 70
8 Transplant Diagnostics Market, By Products and Services
8.1 Introduction 73
8.1.1 Instruments 75
8.1.2 Reagents & Consumables 76
8.1.3 Software and Services 76
9 Transplant Diagnostics Market, By Screening Type
9.1 Introduction 78
9.1.1 Pre-Transplant Screening 79
9.1.2 Post-Transplant Screening 79
10 Transplant Diagnostics Market, By Organ Type
10.1 Introduction 81
10.1.1 Kidney 82
10.1.2 Liver 82
10.1.3 Heart 83
10.1.4 Lung 83
10.1.5 Pancreas 83
11 Transplant Diagnostics Market, By Application Type
11.1 Introduction 85
11.1.1 Research Applications 86
11.1.2 Diagnostic Applications 86
12 Transplant Diagnostics Market, By End User
12.1 Introduction 88
12.1.1 Commercial Service Providers 89
12.1.2 Hospitals and Transplant Centres 89
12.1.3 Research Laboratories and Academic Institutes 89
13 Global Transplant Diagnostics Market, By Region
13.1 Introduction 91
13.2 Americas 92
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.2.1 North America 93
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.2.1.1 U.S. 97
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.2.1.2 Canada 100
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.2.2 South America 104
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.3 Europe 108
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.3.1 Germany 112
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.3.2 U.K 116
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.3.3 France 119
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.3.4 Spain 123
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.3.5 Italy 126
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.3.6 Rest of Europe 130
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.4 Asia Pacific 134
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.4.1 China 138
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.4.2 Japan 142
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.4.3 India 145
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.4.4 Australia 149
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.4.5 Rest of Asia Pacific 152
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.5 Middle East & Africa 156
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.5.1 Middle East 160
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
13.5.2 Africa 164
Transplant Diagnostics Market, By Products and Services
Transplant Diagnostics Market, By Screening Type
Transplant Diagnostics Market, By Organ Type
Transplant Diagnostics Market, By Application Type
Transplant Diagnostics Market, By End User
14 Competitive Landscape
14.1 Company Market Share Analysis 169
14.1.1 Introduction 169
14.2 Competitive Landscape 170
14.2.1 Introduction 170
14.3 Key Developments 171
15 Company Profiles
15.1 Thermo Fisher Scientific Inc. 175
15.1.1 Company Overview 175
15.1.2 Financial Overview 175
15.1.3 Products Offering 176
15.1.4 Key Developments 176
15.1.5 SWOT Analysis 176
15.1.6 Key Strategy 177
15.2 Bio-Rad Laboratories, Inc. 178
15.2.1 Company Overview 178
15.2.2 Financial Overview 178
15.2.3 Products Offering 179
15.2.4 Key Developments 179
15.2.5 SWOT Analysis 179
15.2.6 Key Strategy 180
15.3 F. Hoffmann-La Roche AG 181
15.3.1 Company Overview 181
15.3.2 Financial Overview 181
15.3.3 Products Offering 182
15.3.4 Key Developments 182
15.3.5 SWOT Analysis 183
15.3.6 Key Strategy 183
15.4 Qiagen N.V. 184
15.4.1 Company Overview 184
15.4.2 Financial Overview 184
15.4.3 Products Offering 185
15.4.4 Key Developments 185
15.4.5 SWOT Analysis 185
15.4.6 Key strategy 185
15.5 BioMérieux SA 186
15.5.1 Company Overview 186
15.5.2 Financial Overview 186
15.5.3 Products Offering 187
15.5.4 Key Developments 187
15.5.5 SWOT Analysis 187
15.5.6 Key Strategy 187
15.6 Illumina, Inc. 188
15.6.1 Company Overview 188
15.6.2 Financial Overview 188
15.6.3 Products Offering 189
15.6.4 Key Developments 189
15.6.5 SWOT Analysis 190
15.6.6 Key Strategy 190
15.7 Becton, Dickinson and Company 191
15.7.1 Company Overview 191
15.7.2 Financial Overview 191
15.7.3 Products Offering 192
15.7.4 Key Developments 192
15.7.5 SWOT Analysis 192
15.7.6 Key Strategy 193
15.8 Caredx, Inc. 194
15.8.1 Company Overview 194
15.8.2 Financial Overview 194
15.8.3 Products Offering 195
15.8.4 Key Developments 195
15.8.5 SWOT Analysis 195
15.8.6 Key Strategy 196
15.9 Gendx 197
15.9.1 Company Overview 197
15.9.2 Financial Overview 197
15.9.3 Products Offering 197
15.9.4 Key Developments 197
15.9.5 SWOT Analysis 198
15.9.6 Key Strategy 198
15.10 Zimmer Biomet 199
15.10.1 Company Overview 199
15.10.2 Financial Overview 199
15.10.3 Products Offering 200
15.10.4 Key Developments 200
15.10.5 SWOT Analysis 200
15.10.6 Key Strategy 200
15.11 Medtronic PLC 201
15.11.1 Company Overview 201
15.11.2 Financial Overview 201
15.11.3 Products Offering 202
15.11.4 Key Developments 202
15.11.5 SWOT Analysis 202
15.11.6 Key Strategy 202
15.12 DiaSorin S.P.A 203
15.12.1 Company Overview 203
15.12.2 Financial Overview 203
15.12.3 Products Offering 204
15.12.4 Key Developments 204
15.12.5 SWOT Analysis 204
15.12.6 Key Strategy 204
15.13 Merck KGaA 205
15.13.1 Company Overview 205
15.13.2 Financial Overview 205
15.13.3 Products Offering 206
15.13.4 Key Developments 206
15.13.5 SWOT Analysis 206
15.13.6 Key Strategy 207
15.14 Immucor, Inc. 208
15.14.1 Company Overview 208
15.14.2 Financial Overview: 208
15.14.3 Products Offering 208
15.14.4 Key Developments 208
15.14.5 SWOT Analysis 209
15.14.6 Key strategy 209
16 Appendix
16.1 Discussion Blue Print 211
16.2 Reference 214
17 List of Tables
TABLE 1 MARKET SYNOPSIS 22
TABLE 2 LIST OF ASSUMPTIONS 25
TABLE 3 PRIMARY INTERVIEWS 31
TABLE 4 GLOBAL IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY REGION 2020-2027 (USD MILLION) 47
TABLE 5 AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2020-2027 (USD MILLION) 48
TABLE 6 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020-2027 (USD MILLION) 48
TABLE 7 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
2020-2027 (USD MILLION) 48
TABLE 8 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2020-2027 (USD MILLION) 49
TABLE 9 NORTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 49
TABLE 10 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 50
TABLE 11 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 50
TABLE 12 US IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 50
TABLE 13 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 51
TABLE 14 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 51
TABLE 15 CANADA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 51
TABLE 16 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
2020-2027 (USD MILLION) 52
TABLE 17 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2020-2027 (USD MILLION) 52
TABLE 18 SOUTH AMERICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 52
TABLE 19 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020-2027 (USD MILLION) 53
TABLE 20 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 53
TABLE 21 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 53
TABLE 22 EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 54
TABLE 23 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 54
TABLE 24 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 54
TABLE 25 GERMANY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 55
TABLE 26 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 55
TABLE 27 U.K TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 55
TABLE 28 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 56
TABLE 29 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 56
TABLE 30 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 56
TABLE 31 FRANCE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 57
TABLE 32 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 57
TABLE 33 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 57
TABLE 34 SPAIN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 58
TABLE 35 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 58
TABLE 36 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 58
(USD MILLION) 58
TABLE 37 ITALY IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 59
TABLE 38 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
2020-2027 (USD MILLION) 59
TABLE 39 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2020-2027 (USD MILLION) 59
TABLE 40 REST OF EUROPE IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 60
TABLE 41 ASIA PACFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020-2027 (USD MILLION) 61
TABLE 42 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 61
TABLE 43 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2020-2027 (USD MILLION) 61
TABLE 44 ASIA PACIFIC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 62
TABLE 45 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 62
TABLE 46 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 62
TABLE 47 CHINA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 63
TABLE 48 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 63
TABLE 49 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 63
TABLE 50 JAPAN IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 64
TABLE 51 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 64
TABLE 52 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 64
TABLE 53 INDIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 65
TABLE 54 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 65
TABLE 55 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2020-2027 (USD MILLION) 65
TABLE 56 AUSTRALIA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 66
TABLE 57 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 66
TABLE 58 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2020-2027 (USD MILLION) 66
TABLE 59 REST OF APAC IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 67
TABLE 60 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY REGION 2020-2027 (USD MILLION) 68
TABLE 61 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING
2020-2027 (USD MILLION) 68
TABLE 62 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2020-2027 (USD MILLION) 68
TABLE 63 MIDDLE EAST & AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 69
TABLE 64 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 69
TABLE 65 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG
2020-2027 (USD MILLION) 69
TABLE 66 MIDDLE EAST IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 70
TABLE 67 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY MOLECULAR HLA TYPING 2020-2027 (USD MILLION) 70
TABLE 68 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY IMMUNOSUPPRESSANT DRUG 2020-2027 (USD MILLION) 70
TABLE 69 AFRICA IMMUNOSUPPRESSANT DRUG MONITORING MARKET, BY TEST TYPE 2020-2027 (USD MILLION) 71
TABLE 70 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 73
TABLE 71 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 74
TABLE 72 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 74
TABLE 73 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 74
TABLE 74 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 75
TABLE 75 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 75
TABLE 76 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION 2020-2027 (USD MILLION) 75
TABLE 77 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR REAGENTS & CONSUMABLES, BY REGION 2020-2027 (USD MILLION) 76
TABLE 78 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION 2020-2027 (USD MILLION) 76
TABLE 79 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 78
TABLE 80 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR PRE-TRANSPLANT SCREENING, BY REGION 2020-2027 (USD MILLION) 79
TABLE 81 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR POST-TRANSPLANT SCREENING, BY REGION 2020-2027 (USD MILLION) 79
TABLE 82 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 81
TABLE 83 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR KIDNEY, BY REGION 2020-2027 (USD MILLION) 82
TABLE 84 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR LIVER, BY REGION 2020-2027 (USD MILLION) 82
TABLE 85 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR HEART, BY REGION 2020-2027 (USD MILLION) 83
TABLE 86 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR LUNG, BY REGION 2020-2027 (USD MILLION) 83
TABLE 87 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR PANCREAS, BY REGION 2020-2027 (USD MILLION) 83
TABLE 88 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 85
TABLE 89 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 86
TABLE 90 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH APPLICATIONS, BY REGION 2020-2027 (USD MILLION) 86
TABLE 91 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION 2020-2027 (USD MILLION) 86
TABLE 92 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 88
TABLE 93 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR COMMERCIAL SERVICE PROVIDERS, BY REGION 2020-2027 (USD MILLION) 89
TABLE 94 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR HOSPITALS AND TRANSPLANT CENTERS, BY REGION
2020-2027 (USD MILLION) 89
TABLE 95 GLOBAL TRANSPLANT DIAGNOSTICS MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION
2020-2027 (USD MILLION) 89
TABLE 96 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2020-2027 (USD MILLION) 91
TABLE 97 AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2020-2027 (USD MILLION) 92
TABLE 98 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020-2027 (USD MILLION) 93
TABLE 99 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 93
TABLE 100 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 94
TABLE 101 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 94
TABLE 102 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 94
TABLE 103 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 94
TABLE 104 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 95
TABLE 105 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 95
TABLE 106 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 95
TABLE 107 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 96
TABLE 108 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 96
TABLE 109 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 96
TABLE 110 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 97
TABLE 111 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 97
TABLE 112 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 97
TABLE 113 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 97
TABLE 114 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 98
TABLE 115 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 98
TABLE 116 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 98
TABLE 117 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 99
TABLE 118 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 99
TABLE 119 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 99
TABLE 120 U.S. TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 100
TABLE 121 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 100
TABLE 122 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 100
TABLE 123 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 101
TABLE 124 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 101
TABLE 125 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 101
TABLE 126 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 101
TABLE 127 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 102
TABLE 128 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 102
TABLE 129 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 102
TABLE 130 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 103
TABLE 131 CANADA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 103
TABLE 132 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 104
TABLE 133 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 104
TABLE 134 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 104
TABLE 135 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 104
TABLE 136 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 105
TABLE 137 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 105
TABLE 138 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 105
TABLE 139 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 106
TABLE 140 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 106
TABLE 141 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 106
TABLE 142 SOUTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 107
TABLE 143 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020-2027 (USD MILLION) 108
TABLE 144 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 109
TABLE 145 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 109
TABLE 146 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 109
TABLE 147 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 109
TABLE 148 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 110
TABLE 149 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 110
TABLE 150 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 110
TABLE 151 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 111
TABLE 152 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 111
TABLE 153 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 111
TABLE 154 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 112
TABLE 155 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 112
TABLE 156 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 112
TABLE 157 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 113
TABLE 158 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 113
TABLE 159 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 113
TABLE 160 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 113
TABLE 161 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 114
TABLE 162 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 114
TABLE 163 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 114
TABLE 164 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 115
TABLE 165 GERMANY TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 115
TABLE 166 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 116
TABLE 167 U.K TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 116
TABLE 168 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 116
TABLE 169 U.K TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 116
TABLE 170 U.K TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 117
TABLE 171 U.K TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 117
TABLE 172 U.K TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 117
TABLE 173 U.K TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 118
TABLE 174 U.K TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 118
TABLE 175 U.K TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 118
TABLE 176 U.K TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 119
TABLE 177 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 119
TABLE 178 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 119
TABLE 179 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 120
TABLE 180 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 120
TABLE 181 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 120
TABLE 182 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 120
TABLE 183 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 121
TABLE 184 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 121
TABLE 185 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 121
TABLE 186 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 122
TABLE 187 FRANCE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 122
TABLE 188 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 123
TABLE 189 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 123
TABLE 190 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 123
TABLE 191 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 123
TABLE 192 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 124
TABLE 193 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 124
TABLE 194 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 124
TABLE 195 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 125
TABLE 196 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 125
TABLE 197 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 125
TABLE 198 SPAIN TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 126
TABLE 199 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 126
TABLE 200 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 126
TABLE 201 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 127
TABLE 202 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 127
TABLE 203 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 127
TABLE 204 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 127
TABLE 205 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 128
TABLE 206 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 128
TABLE 207 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 128
TABLE 208 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 129
TABLE 209 ITALY TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 129
TABLE 210 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 130
TABLE 211 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 130
TABLE 212 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 130
TABLE 213 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 130
TABLE 214 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 131
TABLE 215 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 131
TABLE 216 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 131
TABLE 217 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 132
TABLE 218 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 132
TABLE 219 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 132
TABLE 220 REST OF EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 133
TABLE 221 ASIA PACFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020-2027 (USD MILLION) 134
TABLE 222 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 135
TABLE 223 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 135
TABLE 224 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 135
TABLE 225 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 136
TABLE 226 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 136
TABLE 227 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 136
TABLE 228 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 136
TABLE 229 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 137
TABLE 230 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 137
TABLE 231 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 137
TABLE 232 ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 138
TABLE 233 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 138
TABLE 234 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 138
TABLE 235 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 139
TABLE 236 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 139
TABLE 237 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 139
TABLE 238 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 139
TABLE 239 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 140
TABLE 240 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 140
TABLE 241 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 140
TABLE 242 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 141
TABLE 243 CHINA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 141
TABLE 244 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 142
TABLE 245 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 142
TABLE 246 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 142
TABLE 247 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 142
TABLE 248 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 143
TABLE 249 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 143
TABLE 250 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 143
TABLE 251 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 144
TABLE 252 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 144
TABLE 253 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 144
TABLE 254 JAPAN TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 145
TABLE 255 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 145
TABLE 256 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 145
TABLE 257 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 146
TABLE 258 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 146
TABLE 259 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 146
TABLE 260 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 146
TABLE 261 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 147
TABLE 262 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 147
TABLE 263 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 147
TABLE 264 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 148
TABLE 265 INDIA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 148
TABLE 266 AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 149
TABLE 267 AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 149
TABLE 268 AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 149
TABLE 269 AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 149
TABLE 270 AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 150
TABLE 271 AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 150
TABLE 272 AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 150
TABLE 273 AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 151
TABLE 274 AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 151
TABLE 275 AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 151
TABLE 276 AUSTRALIA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 152
TABLE 277 REST OF ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 152
TABLE 278 REST OF ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 152
TABLE 279 REST OF ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 153
TABLE 280 REST OF ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 153
TABLE 281 REST OF ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 153
TABLE 282 REST OF ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 153
TABLE 283 REST OF ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 154
TABLE 284 REST OF ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 154
TABLE 285 REST OF ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 154
TABLE 286 REST OF ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 155
TABLE 287 REST OF ASIA PACIFIC TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 155
TABLE 288 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020-2027 (USD MILLION) 156
TABLE 289 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 157
TABLE 290 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 157
TABLE 291 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 157
TABLE 292 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 157
TABLE 293 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 158
TABLE 294 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 158
TABLE 295 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 158
TABLE 296 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 159
TABLE 297 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 159
TABLE 298 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 159
TABLE 299 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 160
TABLE 300 MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 160
TABLE 301 MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 160
TABLE 302 MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 161
TABLE 303 MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 161
TABLE 304 MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 161
TABLE 305 MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 161
TABLE 306 MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 162
TABLE 307 MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 162
TABLE 308 MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 162
TABLE 309 MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 163
TABLE 310 MIDDLE EAST TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 163
TABLE 311 AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020-2027 (USD MILLION) 164
TABLE 312 AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY REAGENTS & CONSUMABLES 2020-2027 (USD MILLION) 164
TABLE 313 AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY ASSAY & KITS 2020-2027 (USD MILLION) 164
TABLE 314 AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY MOLECULAR ASSAY 2020-2027 (USD MILLION) 164
TABLE 315 AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY PCR-BASED ASSAY 2020-2027 (USD MILLION) 165
TABLE 316 AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY SEQUENCING-BASED ASSAY 2020-2027 (USD MILLION) 165
TABLE 317 AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020-2027 (USD MILLION) 165
TABLE 318 AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020-2027 (USD MILLION) 166
TABLE 319 AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020-2027 (USD MILLION) 166
TABLE 320 AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY DIAGNOSTIC APPLICATIONS 2020-2027 (USD MILLION) 166
TABLE 321 AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020-2027 (USD MILLION) 167
TABLE 322 GLOBAL TRANSPLANT DIAGNOSTIC MARKET: KEY DEVELOPMENT 171
18 List of Figures
FIGURE 1 GLOBAL TRANSPLANT DIAGNOSTICS MARKET: MARKET STRUCTURE 26
FIGURE 2 RESEARCH METHODOLOGY 28
FIGURE 3 DATA TRIANGULATION METHOD 33
FIGURE 4 TOP DOWN & BOTTOM UP APPROACH 34
FIGURE 5 GLOBAL TRANSPLANT DIAGNOSTICS MARKET: MICHAEL PORTER'S FIVE FORCES MODEL 42
FIGURE 6 GLOBAL TRANSPLANT DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS 44
FIGURE 7 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCTS AND SERVICES 2020 & 2027 (USD MILLION) 74
FIGURE 8 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY SCREENING TYPE 2020 & 2027 (USD MILLION) 78
FIGURE 9 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY ORGAN TYPE 2020 & 2027 (USD MILLION) 82
FIGURE 10 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 2020 & 2027 (USD MILLION) 85
FIGURE 11 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END USER 2020 & 2027 (USD MILLION) 88
FIGURE 12 GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2020 & 2027 (USD MILLION) 91
FIGURE 13 AMERICAS TRANSPLANT DIAGNOSTICS MARKET, BY REGION 2020 & 2027 (USD MILLION) 92
FIGURE 14 NORTH AMERICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020 (%) 93
FIGURE 15 EUROPE TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020 (%) 108
FIGURE 16 ASIA PACFIC TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020 & 2027 (USD MILLION) 135
FIGURE 17 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY COUNTRY 2020 & 2027 (USD MILLION) 156
FIGURE 18 GLOBAL TRANSPLANT DIAGNOSTIC MARKET, MARKET SHARE ANALYSIS 2020 (%) 169
FIGURE 19 GLOBAL TRANSPLANT DIAGNOSTIC MARKET COMPETITIVE LANDSCAPE (%) 170
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
